Company Filing History:
Years Active: 2017
Title: **Kwok Wang Hung: Innovator in Neuroprotective Treatments**
Introduction
Kwok Wang Hung, based in Hong Kong, CN, is an accomplished inventor recognized for his significant contributions to the field of neuroprotection. He has developed an innovative approach to treat neurodegenerative disorders, particularly focusing on diseases such as Alzheimer’s.
Latest Patents
Kwok Wang Hung holds a patent for "EphA4 inhibitors as neuroprotective agents." This groundbreaking discovery highlights the role of EphA4 signaling in neurodegenerative disorders that involve β-amyloid induced neurotoxicity. The patent outlines new therapeutic methods, agents, and kits designed to treat diseases associated with overactivated EphA4 signaling. Furthermore, it provides methodologies for identifying additional compounds that could serve as therapeutic agents for conditions linked to excessive EphA4 activity.
Career Highlights
Currently, Kwok is affiliated with The Hong Kong University of Science and Technology, where he continues to advance research in neuroprotection. His work has been instrumental in shedding light on potential treatments for debilitating neurodegenerative conditions that affect millions globally.
Collaborations
Throughout his career, Kwok has had the opportunity to collaborate with distinguished colleagues, including Nancy Yuk Yu Ip and Kit Yu Fu. Their collective expertise enriches the research environment and fosters innovation in therapeutic solutions.
Conclusion
Kwok Wang Hung exemplifies the spirit of innovation in the scientific community. With his patent on EphA4 inhibitors, he opens new doors for therapeutic interventions in neurodegenerative diseases, reflecting the significant impact of dedicated inventors in advancing healthcare. His work not only inspires future research but also offers hope for those affected by these challenging conditions.